Literature DB >> 8851515

Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.

B Malinowska1, E Schlicker.   

Abstract

1. The influence of beta 1-, beta 2-, and beta 3-adrenoceptor agonists and of CGP 12177 and cyanopindolol on heart rate and diastolic blood pressure was studied in the pithed rat. 2. The beta 1-adrenoceptor agonist, prenalterol, increased heart rate and the beta 2-adrenoceptor agonist, fenoterol, caused a fall in blood pressure. The effect of prenalterol was antagonized by the beta 1-adrenoceptor antagonist, CGP 20712 0.1 mumol kg-1 and the action of fenoterol was attenuated by the beta 2-adrenoceptor antagonist, ICI 118551 0.1 mumol kg-1. Both effects were markedly diminished by the non-selective beta-adrenoceptor antagonist, bupranolol 0.1 mumol kg-1. 3. The non-selective beta-adrenoceptor agonist, isoprenaline, three beta 3-agonists as well as CGP 12177 and cyanopindolol elicited a positive chronotropic effect, exhibiting the following pED delta 60 values (negative log values of the doses increasing heart rate by 60 beats min-1): isoprenaline 10.4, CGP 12177 8.3, cyanopindolol 7.2, BRL 37344 6.9, ZD 2079 5.2 and CL 316243 < 5. 4. CGP 20712 0.1 mumol kg-1, given together with ICI 118551 0.1 mumol kg-1, markedly attenuated the positive chronotropic effect of isoprenaline, BRL 37344, ZD 2079 and CL 316243 without affecting the increase in heart rate produced by CGP 12177 and cyanopindolol. 5. The positive chronotropic effect of CGP 12177 and cyanopindolol was attenuated by CGP 20712, 1 and 10 mumol kg-1 and bupranolol, 10 mumol kg-1 but was not affected by ICI 118551, 10 mumol kg-1. The effect of CGP 12177 was also not changed by BRL 37344 1 mumol kg-1, ZD 2079 10 mumol kg-1, CL 316243 10 mumol kg-1, the alpha 1-adrenoceptor antagonist, prazosin 1 mumol kg-1 and the 5-hydroxytryptamine 5-HT2A receptor antagonist, ketanserin 3 mumol kg-1. 6. CGP 12177 0.002 mumol kg-1 and cyanopindolol 0.003 mumol kg-1 shifted to the right the dose-response curve of prenalterol for its positive chronotropic effect. The -log values of the doses causing a twofold shift to the right were 9.6 and 9.5, respectively. 7. Isoprenaline 0.00001-0.001 mumol kg-1, BRL 37344 0.01-1 mumol kg-1 and CGP 12177 0.1 mumol kg-1 caused a fall in diastolic blood pressure which was markedly attenuated by combined administration of CGP 20712 and ICI 118551, 0.1 mumol kg-1 each. 8. CGP 12177 0.01 and 0.1 mumol kg-1 and cyanopindolol 1 mumol kg-1 elicited an increase in diastolic blood pressure. CGP 20712, ICI 118551, bupranolol and, in the case of CGP 12177, also BRL 37344, ZD 2079, CL 316243, prazosin and ketanserin did not influence this effect. 9. In conclusion, the positive chronotropic effect of CGP 12177 and cyanopindolol is not mediated via beta 1-, beta 2-, beta 3-, alpha 1-adrenoceptors or 5-HT2A receptors. This effect may involve atypical beta-adrenoceptors, similar or identical to those described by Kaumann (1989) in isolated heart preparations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851515      PMCID: PMC1909427          DOI: 10.1111/j.1476-5381.1996.tb15285.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

Review 1.  Is there a third heart beta-adrenoceptor?

Authors:  A J Kaumann
Journal:  Trends Pharmacol Sci       Date:  1989-08       Impact factor: 14.819

2.  Molecular characterization of the human beta 3-adrenergic receptor.

Authors:  L J Emorine; S Marullo; M M Briend-Sutren; G Patey; K Tate; C Delavier-Klutchko; A D Strosberg
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

3.  Molecular cloning and expression of the rat beta 3-adrenergic receptor.

Authors:  J G Granneman; K N Lahners; A Chaudhry
Journal:  Mol Pharmacol       Date:  1991-12       Impact factor: 4.436

Review 4.  Beta 3 and atypical beta-adrenoceptors.

Authors:  J R Arch; A J Kaumann
Journal:  Med Res Rev       Date:  1993-11       Impact factor: 12.944

5.  Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of beta-adrenoceptor subtypes in the dissociation between blockade and stimulation.

Authors:  M Walter; H Lemoine; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

6.  Identification of endothelial H1, vascular H2 and cardiac presynaptic H3 receptors in the pithed rat.

Authors:  B Malinowska; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

7.  The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms.

Authors:  G Tavernier; J Galitzky; A Bousquet-Melou; J L Montastruc; M Berlan
Journal:  J Pharmacol Exp Ther       Date:  1992-12       Impact factor: 4.030

8.  Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs.

Authors:  Y T Shen; H Zhang; S F Vatner
Journal:  J Pharmacol Exp Ther       Date:  1994-01       Impact factor: 4.030

9.  Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.

Authors:  N Blin; L Camoin; B Maigret; A D Strosberg
Journal:  Mol Pharmacol       Date:  1993-12       Impact factor: 4.436

10.  Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.

Authors:  M Berlan; J Galitzky; A Bousquet-Melou; M Lafontan; J L Montastruc
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030

View more
  22 in total

1.  Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.

Authors:  D Sarsero; P Molenaar; A J Kaumann; N S Freestone
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 2.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  The 'state' of beta-adrenoceptors.

Authors:  Peter Molenaar
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

4.  Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.

Authors:  Ana M Briones; Craig J Daly; Francesc Jimenez-Altayo; Sonia Martinez-Revelles; Jose M Gonzalez; John C McGrath; Elisabet Vila
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

5.  Positive inotropic and lusitropic effects mediated via the low-affinity state of beta1-adrenoceptors in pithed rats.

Authors:  Agnieszka Zakrzeska; Eberhard Schlicker; Grzegorz Kwolek; Hanna Kozłowska; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 6.  Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Authors:  Ebru Arioglu-Inan; Gizem Kayki-Mutlu; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

7.  Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.

Authors:  L Brawley; A M Shaw; A MacDonald
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

8.  MH-3: evidence for non-competitive antagonism towards the low-affinity site of β1-adrenoceptors.

Authors:  Eberhard Schlicker; Anna Pędzińska-Betiuk; Hanna Kozłowska; Natalia Szkaradek; Dorota Żelaszczyk; Marta Baranowska-Kuczko; Katarzyna Kieć-Kononowicz; Henryk Marona; Barbara Malinowska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-05-03       Impact factor: 3.000

9.  Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.

Authors:  Jillian G Baker; Richard G W Proudman; Stephen J Hill
Journal:  Mol Pharmacol       Date:  2014-03-07       Impact factor: 4.436

10.  A study of antagonist affinities for the human histamine H2 receptor.

Authors:  J G Baker
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.